Literature Citations
1. A Novel Series of (E)-S and (E)-N,S-Polyhalonitrobutadiene Analogues: Design and Evaluation of Antibacterial and Antifungicidial Activity. Abdassalam, A., N.G. Deniz, C. Sayil, S.G. Aydinli, V. Lubenets, O. Komarovska-Porokhnyavets, V. Zvarych, and M. Stasevych. Journal of Chemical Sciences, 2021. 133(4): 132. ISI[000723637000001].
[WOS]. TB_12_2021.
2. Syntheses and Structural Characterization of Metal Complexes of 4-(Naphthalen-1-yl)-1-(quinolin-2-yl)methylene)thiosemicarbazide: Their in-vitro Screening Studies for Antitubercular Activity. Hegde, P.L., K. Naik, S.S. Bhat, S.A. Shaikh, R.J. Butcher, S. Naveen, N.K. Lokanath, and V.K. Revankar. Journal of Coordination Chemistry, 2021. ISI[000723458500001].
[WOS]. TB_12_2021.
3. Activity of Semi-synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis. Martínez-González, M.A., L.M. Peña-Rodríguez, A.H. Uc-Cachón, J. Bórquez, M.J. Simirgiotis, H.B. Barrios-García, R. Hernández-Pando, L.A. Loyola, C. Areche, A.J. Dzul-Beh, J.A. Barrios-Payán, D. Mata-Espinosa, F. Escalante-Erosa, K. García-Sosa, and G.M. Molina-Salinas. Metabolites, 2021. 11(12): 876. PMID[34940634]. PMCID[PMC8703773].
[PubMed]. TB_12_2021.
4. Design and Characterisation of Piperazine-benzofuran Integrated Dinitrobenzenesulfonamide as Mycobacterium tuberculosis H37rv Strain Inhibitors. Murthy, V.S., Y. Tamboli, V.S. Krishna, D. Sriram, S. Akber Ansari, A.A. Alarfaj, A.H. Hirad, and V. Vijayakumar. Journal of Enzyme Inhibition and Medicinal Chemistry, 2021. 36(1): p. 1751-1759. PMID[34325595]. PMCID[PMC8330757].
[PubMed]. TB_12_2021.
5. Antimycobacterial Compound of Chitosan and Ethambutol: Ultrastructural Biological Evaluation in Vitro against Mycobacterium tuberculosis. Oliveira, M., Y.J.A. Silva, L.A. Azevedo, L.A. Linhares, L.M.L. Montenegro, S. Alves, Jr., and R.V.S. Amorim. Applied Microbiology and Biotechnology, 2021. 105(24): p. 9167-9179. PMID[34841463].
[PubMed]. TB_12_2021.
6. Chromane Derivatives from Underground Parts of Iris tenuifolia and Their in Vitro Antimicrobial, Cytotoxicity and Antiproliferative Evaluation. Otgon, O., S. Nadmid, C. Paetz, H.M. Dahse, K. Voigt, S. Bartram, W. Boland, and E. Dagvadorj. Molecules, 2021. 26(21): 6705. PMID[34771113]. PMCID[PMC8588511].
[PubMed]. TB_12_2021.
7. Anti-tuberculosis Activity of Pediococcus acidilactici Isolated from Young Radish Kimchi against Mycobacterium tuberculosis. Yoon, Y., H. Seo, S. Kim, Y. Lee, M.A. Rahim, S. Lee, and H.Y. Song. Journal of Microbiology and Biotechnology, 2021. 31(12): p. 1632-1642. PMID[34584040].
[PubMed]. TB_12_2021.
8. Novel C-3-(N-alkyl-aryl)-Aminomethyl Rifamycin Sv Derivatives Exhibit Activity against Rifampicin-resistant Mycobacterium tuberculosis RpoB(S522L) Strain and Display a Different Binding Mode at the RNAP β-subunit Site Compared to Rifampicin. Zloh, M., M. Gupta, T. Parish, and F. Brucoli. European Journal of Medicinal Chemistry, 2021. 225: 113734. PMID[34418786].
[PubMed]. TB_12_2021.
Patent Citations
This month, no relevant Mycobacterium patents were identified.